Nishizawa, Yoshitaka
Thompson, Kaitlyn C. http://orcid.org/0000-0002-8565-8033
Yamanashi, Takehiko
Wahba, Nadia E.
Saito, Taku
Marra, Pedro S.
Nagao, Takaaki
Nishiguchi, Tsuyoshi
Shibata, Kazuki
Yamanishi, Kyosuke
Hughes, Christopher G.
Pandharipande, Pratik
Cho, Hyunkeun
Howard, Matthew A. III
Kawasaki, Hiroto
Toda, Hiroyuki
Kanazawa, Tetsufumi http://orcid.org/0000-0003-3781-297X
Iwata, Masaaki http://orcid.org/0000-0002-6143-0181
Shinozaki, Gen http://orcid.org/0000-0001-6129-2789
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01 MH119165)
Article History
Received: 3 January 2024
Revised: 15 June 2024
Accepted: 25 June 2024
First Online: 4 July 2024
Competing interests
: GS has pending patents “Epigenetic Biomarker of Delirium Risk” in the PCT Application No. PCT/US19/51276, and in U.S. Provisional Patent No. 62/731,599. All other authors have declared that no conflict of interest exists.